Suppr超能文献

持续性非卧床腹膜透析和中心血液透析患者的住院和门诊医疗保险允许收费比较:一项单中心研究。

A comparison of inpatient and outpatient Medicare allowable charges for continuous ambulatory peritoneal and center hemodialysis patients: a single-center study.

作者信息

Prowant B F, Kappel D F, Campbell A

出版信息

Am J Kidney Dis. 1986 Oct;8(4):248-52. doi: 10.1016/s0272-6386(86)80034-8.

Abstract

Medicare allowable charges were compared between 21 continuous ambulatory peritoneal dialysis (CAPD) and 25 center hemodialysis (CHD) patients for the 12-month period from Sept 1982 through Aug 1983 to determine if savings from CAPD therapy were offset by higher hospitalization charges. All adult patients on a single therapy for the 12-month period who were not dialyzed or hospitalized at other institutions were included. The CAPD and CHD patient groups did not differ significantly by age, sex, or incidence of systemic disease. However, the CHD group had significantly more black patients. The primary renal disease, the incidence of diabetes mellitus, and other systemic diseases did not differ between the groups. The number of hospital admissions was similar between the two groups. However, the CHD patients tended to have a higher number of hospital days than the CAPD group (17.5 v 12.4). Although the total hospital charges tended to be higher for CHD ($16,145) than CAPD patients ($9,872), this difference was not significant. Outpatient dialysis charges were significantly less expensive for CAPD ($16,470) than CHD ($28,233). Emergency department charges were also significantly less for the CAPD group. Charges for patients with and without systemic disease were analyzed separately. In both subgroups, all charges were less for CAPD therapy; however, this difference was significant only for outpatient dialysis charges. Total charges for the 12-month period were significantly less for the CAPD group ($26,453) than for CHD ($45,586). This demonstrates that hospitalization charges did not offset the savings of home dialysis in these patients.

摘要

1982年9月至1983年8月的12个月期间,对21例持续性非卧床腹膜透析(CAPD)患者和25例中心血液透析(CHD)患者的医疗保险允许费用进行了比较,以确定CAPD治疗节省的费用是否被更高的住院费用所抵消。纳入了在这12个月期间接受单一治疗、未在其他机构进行透析或住院的所有成年患者。CAPD组和CHD组在年龄、性别或全身性疾病发病率方面无显著差异。然而,CHD组的黑人患者明显更多。两组之间的原发性肾脏疾病、糖尿病发病率和其他全身性疾病并无差异。两组的住院次数相似。然而,CHD患者的住院天数往往比CAPD组多(17.5天对12.4天)。虽然CHD患者的总住院费用(16,145美元)往往高于CAPD患者(9,872美元),但这种差异并不显著。CAPD的门诊透析费用(16,470美元)明显低于CHD(28,233美元)。CAPD组的急诊科费用也明显更低。对有和没有全身性疾病的患者费用分别进行了分析。在两个亚组中,CAPD治疗的所有费用都更低;然而,这种差异仅在门诊透析费用方面显著。CAPD组12个月期间的总费用(26,453美元)明显低于CHD组(45,586美元)。这表明住院费用并未抵消这些患者家庭透析节省的费用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验